FTY720 Suppresses Liver Tumor Growth and Metastasis by Reducing Circulating Regulating T Cells and Enhancing the Anti-Tumor Effect of Rapamycin.

Li, Chang Xian; Yang, Xin Xiang; Wang, Hong Wei; Li, Xiang Cheng; Ng, Kevin Tak-Pan; Lo, Chung Mau; Man, Kwan.

Afiliação

Li CX; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Living Donor Liver Transplantation, Nanjing, Jiangsu Province, People's Republic of China.
Yang XX; Department of Surgery, The University of Hong Kong, Hong Kong, People's Republic of China.
Wang HW; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Living Donor Liver Transplantation, Nanjing, Jiangsu Province, People's Republic of China.
Li XC; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Living Donor Liver Transplantation, Nanjing, Jiangsu Province, People's Republic of China.
Ng KT; Department of Surgery, The University of Hong Kong, Hong Kong, People's Republic of China.
Lo CM; Department of Surgery, The University of Hong Kong, Hong Kong, People's Republic of China.
Man K; Department of Surgery, The University of Hong Kong, Hong Kong, People's Republic of China.

Onco Targets Ther ; 13: 4743-4754, 2020.

Article em En | MEDLINE | ID: mdl-32547103